According to a new report, published by KBV research, The Global Intraocular Lens Market size is expected to reach $5.1 billion by 2027, rising at a market growth of 5.0% CAGR during the forecast period.
The Ophthalmic Clinics has shown high growth rate of CAGR of 5.2% during (2021 - 2027). Recently, government and non-government groups have concentrated their efforts on ophthalmic research. This is with the goal of developing technologically sophisticated goods and intraocular lenses that have the ability to better fulfill the demands of the patient population. As a result, growing investment in intraocular lens research and development is expected to boost intraocular lens demand at research and academic institutes.
The Multifocal segment is leading the Global Intraocular Lens Market by Product in 2020; thereby, achieving a market value of $2.5 billion by 2027. Due to the many advantages that multifocal intraocular lenses provide, such as high accuracy and better visualization. Furthermore, because they provide three visual zones, multifocal intraocular lenses are effective in treating individuals with complicated diseases and various retinal problems. In comparison to standard mono-focal lenses, these vision zones allow patients to perceive far, mid, and close distances more effectively and precisely.
The North America is fastest growing region in the Global Intraocular Lens Market by Region in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1.7 billion by 2027. The Europe market is anticipated to grow at a CAGR of 4.8% during (2021 - 2027). Additionally, The Asia Pacific market would witness a CAGR of 5% during (2021 - 2027).
Full Report: https://www.kbvresearch.com/intraocular-lens-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Rayner Intraocular Lenses Limited, Bausch Health Companies, Inc., Carl Zeiss AG, Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Hoya Corporation, and Alcon, Inc.
By End-Use
By Product
By Geography
Companies Profiled
Unique Offerings 
